Impact of Sjögren's disease on quality of sexual life using the Qualisex score
- PMID: 39842871
- PMCID: PMC11784214
- DOI: 10.1136/rmdopen-2024-004693
Impact of Sjögren's disease on quality of sexual life using the Qualisex score
Abstract
Objective: This study aimed to assess the impact of Sjögren disease (SjD) on the quality of sexual life and its determinants using the Qualisex questionnaire.
Methods: The Qualisex questionnaire was administered to participants within the ASSESS cohort, a French national multicentric prospective cohort of individuals with SjD. Patients' characteristics and psychometric evaluations were also collected.
Results: Among the 395 patients of the cohort, 92 (23%) completed the questionnaire, with a median age of 56 (44-59) years and a female ratio of 92% (85/92). The median Qualisex score was 3.4 (1.1-5.9).Comparing the first and last quartiles of the Qualisex score, a worst sexual satisfaction was associated with older age (median (IQR) 58 (52-65) vs 52 (41-56) years, p=0.005), higher EULAR Sjögren's disease Patient Reported Index (ESSPRI) (6.8 (5.7-7.7) vs 4.3 (2.8-5.3), p<0.0001) lower SF-36 mental and physical scores (respectively, 43 (38-46) vs 49 (47-53), p=0.0035 and 31 (29-35) vs 35 (30-37), p=0.035), higher Depression and Anxiety scores (HADS) (respectively, 9 (7-11) vs 2 (1-4), p<0.0001 and 11 (8-14) vs 7 (4-10), p=0.006). Interestingly, EULAR Sjögren's disease Disease Activity Index (ESSDAI) score did not differ significantly (4 (1-10) vs 2.5 (1.8-4), p=0.35). In a multivariable analysis, the Qualisex score remained strongly associated with a higher HADS depression score and, to a lesser extent, with a higher ESSPRI. The inability to obtain a score was associated with older age.
Conclusion: In SjD patients, sexual satisfaction assessed with the Qualisex score, was strongly associated with depression and, to lesser extent, with ESSPRI, but not with systemic activity.
Keywords: Epidemiology; Health-Related Quality Of Life; Sjogren's Syndrome.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren's disease by the Brazilian Society of Rheumatology.Adv Rheumatol. 2025 Feb 11;65(1):7. doi: 10.1186/s42358-025-00438-7. Adv Rheumatol. 2025. PMID: 39934881
-
Adherence to Mediterranean Diet and Ocular Dryness Severity in Sjögren's Syndrome: A Cross-Sectional Study.Med Sci (Basel). 2025 May 23;13(2):64. doi: 10.3390/medsci13020064. Med Sci (Basel). 2025. PMID: 40559222 Free PMC article.
-
Long-term changes in Sjögren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.Rheumatol Int. 2025 Jun 17;45(7):156. doi: 10.1007/s00296-025-05909-0. Rheumatol Int. 2025. PMID: 40526294
-
High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort study.Rheumatol Int. 2025 Aug 6;45(8):184. doi: 10.1007/s00296-025-05935-y. Rheumatol Int. 2025. PMID: 40767878
-
A systematic review of primary Sjögren's syndrome in male and paediatric populations.Clin Rheumatol. 2017 Oct;36(10):2225-2236. doi: 10.1007/s10067-017-3745-z. Epub 2017 Jul 22. Clin Rheumatol. 2017. PMID: 28735431 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical